1026786-82-2Relevant articles and documents
A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate
Molinaro, Carmela,Shultz, Scott,Roy, Amélie,Lau, Stephen,Trinh, Thao,Angelaud, Rémy,O'Shea, Paul D.,Abele, Stefan,Cameron, Mark,Corley, Ed,Funel, Jacques-Alexis,Steinhuebel, Dietrich,Weisel, Mark,Krska, Shane
, p. 1062 - 1071 (2011/04/22)
A practical enantioselective synthesis of renin inhibitor MK-1597 (ACT-178882), a potential new treatment for hypertension, is described. The synthetic route provided MK-1597 in nine steps and 29% overall yield from commercially available p-cresol (7). The key features of this sequence include a catalytic asymmetric hydrogenation of a tetrasubstituted ene-ester, a highly efficient epimerization/saponification sequence of 4 which sets both stereocenters of the molecule, and a short synthesis of amine fragment 2.
NOVEL CASE OF RENIN INHIBITORS
-
Page/Page column 33-35, (2009/01/20)
The present invention relates to piperidine-based renin inhibitor compounds having carboxylate or carboxylic acid terminal groups. The disclosed low molecular weight, orally active renin inhibitors are of non-peptide nature and have long duration of action. The compounds can be used in the treatment of cardiovascular events and renal insufficiency.